Tilray Brands Joins European Cannabis Regulation Talks

Tilray Brands is actively participating in discussions regarding medical cannabis regulations in Europe. While the company's stock has seen a modest 19% increase over the past year, analysts maintain a positive outlook, projecting a potential surge of over 50% in the next twelve months. This engagement in regulatory talks signals Tilray's strategic positioning within the evolving European medical cannabis market, potentially influencing future market access and product development.